期刊文献+

氯磷酸二钠修饰羟基磷灰石对颌骨缺损修复的影响

Clodronate modifying hydroxyapatite promotes restoration of mandibular defect
下载PDF
导出
摘要 目的研究氯磷酸二钠修饰羟基磷灰石(hydroxyapatite,HA)在体内外促进骨形成对骨缺损修复效果的影响。方法制备氯磷酸二钠-HA复合材料,以HA为对照;分离培养成骨细胞,接种于氯磷酸二钠-HA和HA支架,四唑盐(methyl thiazolyl tetrazolium,MTT)比色法检测细胞增殖活性,测定碱性磷酸酶(alkaline phosphatase,ALP)活性,实时荧光定量PCR检测成骨细胞骨保护蛋白(osteoprotegerin,OPG)、核因子-κβ受体活化因子配体(receptor activator of nuclear factor kappa beta ligand,RANKL)mRNA表达的变化;进而将氯磷酸二钠-HA和HA植入兔下颌骨缺损区域,改良Masson染色及生物力学检测观察氯磷酸二钠对HA修复颌骨缺损的影响。结果 MTT和ALP活性检测表明成骨细胞在氯磷酸二钠-HA和HA支架上生长的增殖活性差异无统计学意义(P>0.05)。实时荧光定量PCR结果表明,两组细胞RANKL mRNA表达无明显变化,而氯磷酸二钠-HA组OPGmRNA显著上调(P<0.05)。改良Masson染色表明,与HA相比,氯磷酸二钠-HA更有利于材料周围新骨形成。生物力学检测结果表明氯磷酸二钠-HA组的压缩强度、拉伸强度、剪切强度均大于HA组(P<0.05)。结论复合在HA表面的氯磷酸二钠可能通过上调成骨细胞OPG表达,促进新骨形成,提高骨缺损修复的生物力学性能。 Objective To evaluate the effects of clodronate modifying hydroxyapatite(HA) on cultured osteoblasts in vitro,and to observe the function of restoring mandibular defect in vivo.Methods Clodronate-HA composites were prepared,and HA as control;osteoblasts were isolated and cultured,and inoculated on Clodronate-HA and HA scaffold.The proliferation of osteoblasts was detected by methyl thiazolyl tetrazolium( MTT) and alkaline phosphatasel(ALP) activity test,and the mRNA expression of osteoprotegerin(OPG) and receptor activator of nuclear factor kappa beta ligand(RANKL) was detected by quantitative real-time RT-PCR.Clodronate-HA was implanted into rabbit mandibular defects,and the repairing effects were evaluated using Masson staining and biomechanics test.Results MTT and ALP activity test indicated that there was no significant difference between the Clodronate-HA and HA scaffolds in the growth activity of osteoblasts.The results of quantitative real-time RT-PCR showed there was no significant difference between two groups in mRNA expression of RANKL gene,while the expression of OPG gene showed higher expression in Clodronate-HA group(P0.05).Masson staining indicated Clodronate-HA was more beneficial to new bone formation around the material compared with HA.The result of biomechanics test showed the compressive strength,tensile strength and shear strength of Clodronate-HA group were greater than those of HA group(P0.05).Conclusion Clodronate modifying HA could upregulate the expression of OPG in osteoblasts,and be beneficial for HA to repair bone defects.
出处 《广东牙病防治》 2012年第2期61-66,共6页 Journal of Dental Prevention and Treatment
基金 国家自然科学基金(30973346) 新世纪优秀人才支持计划(NCET-10-0597)
关键词 氯磷酸二钠 羟基磷灰石 成骨细胞 骨缺损 Clodronate Hydroxyapatite Osteoblasts Bone defects
  • 相关文献

参考文献19

  • 1ten Broeke RH,Alves A,Baumann A,et al.Bone reaction to a bio-mimetic third-generation hydroxyapatite coating and new surface treat-ment for the Symax hip stem.J Bone Joint Surg Br,2011,93(6):760-768. 被引量:1
  • 2Lee KW,Bae CM,Jung JY,et al.Surface characteristics and bio-logical studies of hydroxyapatite coating by a new method.J BiomedMater Res B Appl Biomater,2011,98B(2):395-407. 被引量:1
  • 3Kannan MB,Orr L.In vitro mechanical integrity of hydroxyapatitecoated magnesium alloy.Biomed Mater,2011,6(4):045003. 被引量:1
  • 4赵玉驰,王大平,赖苑威,熊建义,王力刚,朱伟民,黄仁辉,袁杰.纳米羟基磷灰石纤维蛋白凝胶复合重组人成骨蛋白1修复骨缺损[J].中国组织工程研究与临床康复,2011,15(8):1360-1364. 被引量:3
  • 5王立,戚孟春.二磷酸盐对破骨细胞的影响[J].医学综述,2009,15(23):3521-3523. 被引量:3
  • 6McLeod K,Anderson GI,Dutta NK,et al.Adsorption of bisphos-phonate onto hydroxyapatite using a novel co-precipitation techniquefor bone growth enhancement.J Biomed Mater Res A,2006,79(2):271-281. 被引量:1
  • 7von Knoch M,Wedemeyer C,Pingsmann A,et al.The decrease ofparticle-induced osteolysis after a single dose of bisphosphonate.Bio-materials,2005,26(14):1803-1808. 被引量:1
  • 8von Knoch F,Eckhardt C,Alabre CI,et al.Anabolic effects of bi-sphosphonates on peri-implant bone stock.Biomaterials,2007,28(24):3549-3559. 被引量:1
  • 9刘永江,陆敬义.二磷酸盐治疗前列腺癌骨转移的系统评价[J].中国男科学杂志,2009,23(8):33-37. 被引量:2
  • 10Hiroshi,Kajiwaraa,Takayoshi,et al.The bisphosphonate pamidr-onate on the surface of titanium stimulates bone formation aroundtibial implants in rats.Biomaterials,2005,26(6):581-587. 被引量:1

二级参考文献58

  • 1朱伟民,王大平,熊建义,陈信.纳米羟基磷灰石人工骨修复骨缺损的再血管化研究[J].中国微循环,2006,10(5):344-348. 被引量:5
  • 2Adami S, Salvagno G, Guarrera G, et al. J Urol 1985; 134:1152-1154. 被引量:1
  • 3Carey PO, Lippert MC. Urology 1988; 32(5): 403-407. 被引量:1
  • 4Alderson P, Green S, Higgins JPT, editiorsl. Cochrane Reviewers' Handbook 4.2.1[updated December 2003]. Section 6. In: The Cochrane Library. The Cochrane Collaboration. Oxford :2004, Issue 1. 被引量:1
  • 5Adami S, Mian M. Recent Results Cancer Research 1989; 116:67-72. 被引量:1
  • 6Dearnaley DP, Sydes MR, Mason MD, et al. J Natl Cancer lnst 2003; 95(17): 1300-1311. 被引量:1
  • 7Elomaa I, Kylmata T, Tammela T, et al. lnt J Urol Nephrol 1992; 24(2): 159-166. 被引量:1
  • 8Ernst DS, Tannock IF, Winquist EW, et al. J Clin Oncol 2003; 21(17): 3335-3342. 被引量:1
  • 9Kylmala T, Tammela T, Risteli L, et al. Eur J Cancer 1993; 29A(6): 821-825. 被引量:1
  • 10Kylmala T, Taube T, Tammela TL, et al. Bri J Cancer 1997; 76(7): 939-942. 被引量:1

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部